Breakfast News: Banks Open Their Books

Motley Fool
01-13

Breakfast News: Banks Open Their Books

January 13, 2025

Friday's Markets
S&P 500
5,827 (-1.54%)
Nasdaq
19,162 (-1.63%)
Dow
41,938 (-1.63%)
Bitcoin
$94,885 (+2.93%)

Source: Image created by Jester AI.

1. Earnings Season Rolls Around Again

Big banks kick off another round of earnings this week: JPMorgan (JPM -1.34%), Wells Fargo (WFC -2.25%), Citigroup (C -2.54%), and Goldman Sachs (GS -3.45%) report on Wednesday along with BlackRock (BLK -3.09%). Updates from Bank of America (BAC -2.38%), Morgan Stanley (MS -3.45%), and U.S. Bancorp (USB -2.35%) follow on Thursday.

  • Banks beat earnings expectations throughout 2024: However, analysts are generally forecasting a weaker end to the financial year with these Q4 updates. Hidden Gems rec U.S. Bancorp isn't holding back on pursuing growth, and may be attractive to investors who want to diversify away from high-growth stocks in areas like technology, or who appreciate dividend income.
  • "Something to watch going into 2025 is the state of the consumer": Fool analyst Jason Moser observed "The Financial Times recently reported credit card lenders have written off $46 billion in seriously delinquent balances over the first 9 months of 2024, up a whopping 50% from a year ago and the highest level in 14 years; we'll likely see more of the same when banks report earnings in January."

2. Next Up: Two Key Inflation Prints

Ahead of the Federal Reserve's January 28-29 meeting, Tuesday brings wholesale figures with the December Producer Price Index (PPI). The Consumer Price Index, following on Wednesday, is expected to show a year-over-year rise to 2.9%, from 2.7% in November.

  • "Another speed bump on the road to 2% inflation": Wells Fargo thinks inflation could rise to 2.9%, setting a five-month high. With 256,000 jobs created in December, far more than the expected 165,000, CME's FedWatch tool shows only a 25% probability of a rate cut by the Fed's March meeting.
  • "Good economic news is bad market news": The better-than-expected December jobs report is making investors fear higher interest rates for longer, as Scott Chronert at Citi noted bond yields are rising, which tends to be bad news for stocks.

3. Biotech Buyout

Bloomberg reports Johnson & Johnson (JNJ -0.15%) is working on a bid to buy biotechnology company Intra-Cellular Therapies (ITCI 14.91%). Intra-Cellular, whose bipolar depression treatment Caplyta made $464 million in 2023 sales, closed with a market capitalization of $10 billion on Friday after a 15% jump.

  • Patent cliff: The deal comes as Johnson & Johnson faces a potential $17 billion loss of revenue from the 2029 expiry of its blockbuster Darzalex cancer drug.
  • Biotech acquisitions back on track: 2024 was a quiet year for deals in the sector, but this one would be the biggest since Pfizer (PFE -0.52%) took over Seagen for $43 billion in 2023.

4. The AI Play Investors May Be Overlooking

Sanmeet Deo, CFA

Under the Radar

Beyond the Magnificent Seven, a compelling AI opportunity might be hiding in plain sight: Dell Technologies (DELL -3.81%). While PCs remain part of its business, Dell has quietly transformed into a key player in AI infrastructure. It is building the essential hardware--servers, storage, and networking--that every AI company needs. Think of it as selling the "picks and shovels" during a gold rush.

Dell's AI server customer base has exploded from roughly 30 to over 2,000, with projections exceeding 4,000. This explosive growth signals strong demand. CEO Michael Dell anticipated this trend, strategically acquiring EMC and VMware to create an integrated hardware/software ecosystem optimized for AI. Strong partnerships with Nvidia (NVDA -3.00%) and other chipmakers further solidify their position.

Instead of betting on one specific AI application, Dell provides the foundation for the entire industry. While risks remain – including competition and the uncertainty of long-term AI demand – Dell offers a less volatile opportunity for investors seeking exposure to the AI boom.

5. Foolish Fun

Sometimes the best returns come from companies building the future in plain sight. Which 'sleeping giant' in your portfolio has you convinced despite its current stagnation? Discuss with friends and family, or become a member to hear what your fellow Fools are saying. P.S. Our latest Stock Advisor recommendation is released this Thursday!

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10